Corbus Pharmaceuticals Holdings, Inc. Increase (Decrease) in Contract with Customer, Liability
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Increase (Decrease) in Contract with Customer, Liability of -$3.98 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2019-08-08
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2019-06-30 was -$29.52M.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2019-03-31 was $25.54M.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in contract with customer, liability for fiscal 2018 was -$4.79M.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in contract with customer, liability for fiscal 2017 was -$1.94M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|
| 2019-06-30 | -$29.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$3.98M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $25.54M 10-Q · filed 2019-05-09 | ||
| 2018-12-31 | -$4.79M 10-K · filed 2019-03-12 | ||
| 2018-06-30 | -$1.77M 10-Q · filed 2019-08-08 | ||
| 2017-12-31 | -$1.94M 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |